News
Novo Nordisk has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's ...
Designed specifically for big AI projects, Gefion - named after the Norse goddess of fertility - was funded to the tune of ...
Novo Nordisk, a leading global healthcare company, has announced the signing of a MoU with Lifera, a biopharmaceutical company owned by the Saudi sovereign wealth fund PIF (Public Investment Fund), to ...
Their own mini-boom of recent years has been largely fueled by one firm, Ozempic maker Novo Nordisk A/S, whose diabetes and ...
President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare ...
Eli Lilly announced clinical trial results this week for a daily pill to treat obesity and diabetes. Its name is absolutely ...
Work has begun in the UK on developing new tests that will spot if someone has “fat genes”. The project, which seeks to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results